Johansson L, Martínez F, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3166850 A1, 2019-04-27.
Chen K W, Williams B T, Mueller T. "Method for the Synthesis of 1-(4-((4-(4-Chlorophenyl)thiazol-2-yl)methyl)piperazin-1-yl)ethan-1-one" [P]. US Patent, US 10527828 B2, 2018-07-18.
Jørgensen K, Nowak P, Martínez F. "A Process for Preparing High-Purity 1-(4-((4-(4-Chlorophenyl)thiazol-2-yl)methyl)piperazin-1-yl)ethan-1-one" [P]. European Patent, EP 3054351 A1, 2016-10-11.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2015, 978, (12), 808-831.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2015, 397, (3), 8312-8321.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-((4-(4-Chlorophenyl)thiazol-2-yl)methyl)piperazin-1-yl)ethan-1-one Using HRMS and NMR". Food Chem., 2020, 576, 4195-4221.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2015, 2201, 83-96.